Brochure
JPM 2026 Insights
JPM 2026 Insights by Cyagen: AI Transformation, Globalization 2.0, and Emerging Innovations in Core Modalities from Next-Gen ADCs to Degrader-Antibody Conjugates (DACs)
Overview
Derived from a comprehensive analysis of 109 industry leaders at the 44th J.P. Morgan Healthcare Conference, this report distills four pivotal trends: AI-driven transformation, platform expansion, patient-centricity, and the targeting of undruggable proteins. We provide a deep dive into high-growth arenas like Oncology and Metabolic diseases (specifically the next-gen GLP-1 landscape) and offer forward-looking perspectives on ADC, DAC, and RNA innovations. This report serves as a strategic compass for pharmaceutical R&D and investment decision-making.
Key Insights
Content
- JPM 2026 Overview
- Key Industry Trends
- Targets, Areas & Therapies
- Hot & Potential Directions
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.